Fresenius Medical Care AG & Co. KGaA (FMS) is well-poised for growth on the back of a broad range of dialysis products and services, and a solid global foothold. However, stiff competition remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 5.6% year to date against the industry’s growth of 9.4%. The S&P 500 Index has increased 18.2% in the same time frame.The company, with a market capitalization of $11.41 billion, is one of the largest integrated providers of products and services for ...